HYDRALAZINE 25 MG TABLET
For 30 tablets
Pharmacies pay
$1.07 filed
30 × $0.03572 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$2.66 filed
30 × $0.0887 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
2.5× estimated
Medicare paid 2.5× what pharmacies pay.
Part D averages every strength and form sold under “Hydralazine HCl*” / “Hydralazine HCl” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$6.23 estimated
$1.07 + $0.16 (15%) + $5.00 fee per fill = $6.23
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
HYDRALAZINE 25 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as hydralazine hydrochloride.
FDA gives its dosage form as “tablet” and “tablet, film coated” and its route as oral.
FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. and Camber Pharmaceuticals, Inc.
FDA’s Established Pharmacologic Class for it is Arteriolar Vasodilator.
The NADAC file of 2026-10-14 prices it under 21 NDCs (National Drug Codes); the FDA directory lists 17 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $1.07 for 30 tablets (30 × $0.03572 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 11 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Camber Pharmaceuticals, Inc. | 2 | $0.03572 per EA filed |
| Exelan Pharmaceuticals Inc. | 2 | $0.03572 per EA filed |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2 | $0.03572 per EA filed |
| ScieGen Pharmaceuticals, Inc. | 2 | $0.03572 per EA filed |
| Strides Pharma Science Limited | 2 | $0.03572 per EA filed |
| Teva Pharmaceuticals USA, Inc. | 2 | $0.03572 per EA filed |
| American Health Packaging | 1 | $0.03572 per EA filed |
| Chartwell RX, LLC | 1 | $0.03572 per EA filed |
| Major Pharmaceuticals | 1 | $0.03572 per EA filed |
| Modavar Pharmaceuticals LLC | 1 | $0.03572 per EA filed |
| Mylan Institutional Inc. | 1 | $0.03572 per EA filed |
| Not listed as a package in the FDA directory | 4 | $0.03572 per EA filed |
All 21 NDCs, with labeler and price
- 00904-7448-61 · Major Pharmaceuticals · $0.03572 per EA · eff. 2026-09-23 filed
- 23155-0002-01 · not listed as a package in the FDA directory · $0.03572 per EA · eff. 2026-09-23 filed
- 23155-0002-10 · not listed as a package in the FDA directory · $0.03572 per EA · eff. 2026-09-23 filed
- 23155-0833-01 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.03572 per EA · eff. 2026-09-23 filed
- 23155-0833-10 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.03572 per EA · eff. 2026-09-23 filed
- 31722-0520-01 · Camber Pharmaceuticals, Inc. · $0.03572 per EA · eff. 2026-09-23 filed
- 31722-0520-10 · Camber Pharmaceuticals, Inc. · $0.03572 per EA · eff. 2026-09-23 filed
- 50111-0327-01 · Teva Pharmaceuticals USA, Inc. · $0.03572 per EA · eff. 2026-09-23 filed
- 50111-0327-03 · Teva Pharmaceuticals USA, Inc. · $0.03572 per EA · eff. 2026-09-23 filed
- 50228-0183-01 · ScieGen Pharmaceuticals, Inc. · $0.03572 per EA · eff. 2026-09-23 filed
- 50228-0183-10 · ScieGen Pharmaceuticals, Inc. · $0.03572 per EA · eff. 2026-09-23 filed
- 51079-0075-01 · not listed as a package in the FDA directory · $0.03572 per EA · eff. 2026-09-23 filed
- 51079-0075-20 · Mylan Institutional Inc. · $0.03572 per EA · eff. 2026-09-23 filed
- 60687-0822-01 · American Health Packaging · $0.03572 per EA · eff. 2026-09-23 filed
- 60687-0822-11 · not listed as a package in the FDA directory · $0.03572 per EA · eff. 2026-09-23 filed
- 62135-0580-12 · Chartwell RX, LLC · $0.03572 per EA · eff. 2026-09-23 filed
- 64380-0734-06 · Strides Pharma Science Limited · $0.03572 per EA · eff. 2026-09-23 filed
- 64380-0734-08 · Strides Pharma Science Limited · $0.03572 per EA · eff. 2026-09-23 filed
- 72241-0004-11 · Modavar Pharmaceuticals LLC · $0.03572 per EA · eff. 2026-09-23 filed
- 76282-0310-01 · Exelan Pharmaceuticals Inc. · $0.03572 per EA · eff. 2026-09-23 filed
- 76282-0310-10 · Exelan Pharmaceuticals Inc. · $0.03572 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
3 other products in the NADAC file share the FDA nonproprietary name hydralazine hydrochloride with HYDRALAZINE 25 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| HYDRALAZINE 10 MG TABLET | $0.027 per EA filed | $0.0887 per EA filed |
| HYDRALAZINE 25 MG TABLET this page | $0.03572 per EA filed | $0.0887 per EA filed |
| HYDRALAZINE 50 MG TABLET | $0.04454 per EA filed | $0.0887 per EA filed |
| HYDRALAZINE 100 MG TABLET | $0.0717 per EA filed | $0.0887 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 21 NDCs’ NADAC prices is $0.03572 per EA filed.
Of the 7 other products in FDA’s Arteriolar Vasodilator class priced per EA, 6 have a higher middle NADAC price and 1 a lower one. The one in the middle is MINOXIDIL 2.5 MG TABLET, at $0.09821 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $2.66 for 30 tablets, at an average of $0.0887 per EA in 2024 (2024-01-01 to 2024-12-31) for “Hydralazine HCl*” and “Hydralazine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 6,074,425 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
19 of the product’s 21 NDCs have this Medicare figure; the other 2 do not, and the interactive card says why for each.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for HYDRALAZINE 25 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Hydralazine HCl* / Hydralazine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. Only NADAC NDCs whose FDA route includes ORAL point at this name (63 of the 70 the name join matched); NDCs of another route or with no known FDA route do not. 6 of the 63 NDCs that point at this name are not listed in the FDA NDC Directory as packages of their own; their route was taken from FDA's record for the same product (labeler and product code).